We use cookies and other data for a number of reasons, such as keeping FT Sites reliable and secure, personalising content and ads, providing social media features and to analyse how our Sites are used.
Add this topic to your myFT Digest for news straight to your inbox
The latest findings build on experiments from over a century ago
Big-selling molnupiravir treatment produces permanent mutations that can be passed from patient to patient
Cambridge university study contradicts common belief in psychology that it is better to talk about distressing ideas and memories
First example of artificial intelligence helping to accelerate diagnosis of diseases caused by genetic variants
Tedros Adhanom Ghebreyesus says health body is ready to send second mission as Omicron variants drive rise in cases
Neither organisations nor people can learn from their errors if they deny mistakes ever happened
Climate change helps the spread of infectious diseases. Plus: rise in fungal infections highlights risks of antimicrobial resistance; Sydney shows how to almost eliminate HIV transmission; wait goes on for effective Long Covid treatments
Unlike the vaccine race, there is limited funding to treat a condition that is often debilitating
Huge resources devoted to examining links with illness
Policymakers are failing to address the likelihood of another pandemic
Leaders must treat these risks as existential — one of very few threats that can change the world in days
Illnesses such as cancer and heart disease supplant likes of HIV
Drug resistance is not just a problem with bacteria
Trial finds latest version elicited better immune response than existing jabs
At least three descendants of Omicron have scientists on alert and vaccination programmes speeding up
Lives of 2mn mothers and babies could be saved by 2030 with small innovations in care, says Gates Foundation
Drug regulator’s decision is the first step towards a new round of jabs as cases rise in the US
Finger-prick technology on mobile device can detect long Covid and Alzheimer’s
Preliminary studies find exposure to prevalent XBB.1.5 strain elicits antibodies to BA.2.86
Stark findings highlight need to increase research into causes and more effective treatment
Researchers say funding for trials is running out because of delays at MHRA
Potential mutations prompts authorities to begin immunisation rollout in September
9/11’s aftermath is an invaluable source for those studying newer shocks
As vaccines are tweaked while new sub-variants emerge, the virus cannot be treated yet as a seasonal bug
New model aims to reduce high development costs and increase number of drugs being tested
International Edition
